As reviewed in Tamburrino et al. [6], epithelial AR levels in primary prostate cancers has been inconsistently related to patient outcome, with 20% of studies suggesting high cancer AR as a prognostic marker of good outcome, 26% showing high AR as a prognostic marker of poor outcome, and the majority showing no relationship (Table 1). This evidence concerns the gene AR and Familial prostate cancer.